Jennifer M. Kim

Array ( [id] => 10450558 [patent_doc_number] => 20150335572 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-11-26 [patent_title] => 'Medicated Hard Candy Product For Treating Esophageal Inflammation And A Method Using The Same' [patent_app_type] => utility [patent_app_number] => 14/720918 [patent_app_country] => US [patent_app_date] => 2015-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 5608 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14720918 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10317195 [patent_doc_number] => 20150202198 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-07-23 [patent_title] => 'Novel Cabergoline Derivatives' [patent_app_type] => utility [patent_app_number] => 14/670953 [patent_app_country] => US [patent_app_date] => 2015-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16148 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14670953 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10412539 [patent_doc_number] => 20150297548 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-22 [patent_title] => 'ALPHA-DERIVATIVES OF CIS-MONOUNSATURATED FATTY ACIDS FOR USE AS MEDICINES' [patent_app_type] => utility [patent_app_number] => 14/664351 [patent_app_country] => US [patent_app_date] => 2015-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 16465 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14664351 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10279919 [patent_doc_number] => 20150164916 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-06-18 [patent_title] => 'ROFLUMILAST COMPOSITIONS FOR THE TREATMENT OF COPD' [patent_app_type] => utility [patent_app_number] => 14/630944 [patent_app_country] => US [patent_app_date] => 2015-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 12175 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14630944 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10654585 [patent_doc_number] => 20160000729 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-01-07 [patent_title] => 'NEURONAL CIRCUIT-DEPENDENT NEUROPROTECTION BY INTERACTION BETWEEN NICOTINIC RECEPTORS' [patent_app_type] => utility [patent_app_number] => 14/630313 [patent_app_country] => US [patent_app_date] => 2015-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 12869 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14630313 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10662155 [patent_doc_number] => 20160008299 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-01-14 [patent_title] => 'NEURONAL CIRCUIT-DEPENDENT NEUROPROTECTION BY INTERACTION BETWEEN NICOTINIC RECEPTORS' [patent_app_type] => utility [patent_app_number] => 14/630357 [patent_app_country] => US [patent_app_date] => 2015-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 12884 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14630357 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10662171 [patent_doc_number] => 20160008315 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-01-14 [patent_title] => 'NEURONAL CIRCUIT-DEPENDENT NEUROPROTECTION BY INTERACTION BETWEEN NICOTINIC RECEPTORS' [patent_app_type] => utility [patent_app_number] => 14/630381 [patent_app_country] => US [patent_app_date] => 2015-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 12917 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14630381 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10662228 [patent_doc_number] => 20160008372 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-01-14 [patent_title] => 'METHODS AND COMPOSITIONS FOR TREATING MIGRAINES USING NORIBOGAINE' [patent_app_type] => utility [patent_app_number] => 14/624292 [patent_app_country] => US [patent_app_date] => 2015-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 28144 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14624292 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10263374 [patent_doc_number] => 20150148371 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-05-28 [patent_title] => 'NOVEL NEUROMODULATORY COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 14/607325 [patent_app_country] => US [patent_app_date] => 2015-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17219 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14607325 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11790042 [patent_doc_number] => 09399612 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-07-26 [patent_title] => 'Treatment of pervasive developmental disorders with redox-active therapeutics' [patent_app_type] => utility [patent_app_number] => 14/605937 [patent_app_country] => US [patent_app_date] => 2015-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16345 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14605937 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10317183 [patent_doc_number] => 20150202186 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-07-23 [patent_title] => 'CYSTATHIONINE-(gamma)-LYASE (CSE) INHIBITORS FOR TREATING PAIN' [patent_app_type] => utility [patent_app_number] => 14/604541 [patent_app_country] => US [patent_app_date] => 2015-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 30199 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14604541 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10412542 [patent_doc_number] => 20150297551 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-22 [patent_title] => '(HET)ARYL-P-QUINONE DERIVATIVES FOR TREATMENT OF MITOCHONDRIAL DISEASES' [patent_app_type] => utility [patent_app_number] => 14/586516 [patent_app_country] => US [patent_app_date] => 2014-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28056 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14586516 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10428865 [patent_doc_number] => 20150313877 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-11-05 [patent_title] => 'TREATMENT OF ADHD' [patent_app_type] => utility [patent_app_number] => 14/586081 [patent_app_country] => US [patent_app_date] => 2014-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11593 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14586081 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10289119 [patent_doc_number] => 20150174118 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-06-25 [patent_title] => 'USE OF LAQUINIMOD TO DELAY HUNTINGTON\'S DISEASE PROGRESSION' [patent_app_type] => utility [patent_app_number] => 14/575357 [patent_app_country] => US [patent_app_date] => 2014-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11833 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14575357 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10220434 [patent_doc_number] => 20150105428 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-04-16 [patent_title] => 'COMPOSITIONS AND METHODS FOR MODULATING CIRCADIAN SYNCHRONIZATION' [patent_app_type] => utility [patent_app_number] => 14/573638 [patent_app_country] => US [patent_app_date] => 2014-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 22197 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14573638 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10220434 [patent_doc_number] => 20150105428 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-04-16 [patent_title] => 'COMPOSITIONS AND METHODS FOR MODULATING CIRCADIAN SYNCHRONIZATION' [patent_app_type] => utility [patent_app_number] => 14/573638 [patent_app_country] => US [patent_app_date] => 2014-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 22197 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14573638 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10279888 [patent_doc_number] => 20150164885 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-06-18 [patent_title] => 'Neferine and the use thereof in treating Huntington disease' [patent_app_type] => utility [patent_app_number] => 14/562780 [patent_app_country] => US [patent_app_date] => 2014-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 4305 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14562780 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10209383 [patent_doc_number] => 20150094373 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-04-02 [patent_title] => 'COMPOUNDS FOR TREATING INFLAMMATION AND PAIN' [patent_app_type] => utility [patent_app_number] => 14/562608 [patent_app_country] => US [patent_app_date] => 2014-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8917 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14562608 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10209375 [patent_doc_number] => 20150094366 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-04-02 [patent_title] => 'COMPOUNDS FOR TREATING INFLAMMATION AND PAIN' [patent_app_type] => utility [patent_app_number] => 14/562620 [patent_app_country] => US [patent_app_date] => 2014-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8500 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14562620 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10095830 [patent_doc_number] => 09132125 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-09-15 [patent_title] => 'Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof' [patent_app_type] => utility [patent_app_number] => 14/557570 [patent_app_country] => US [patent_app_date] => 2014-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 20 [patent_no_of_words] => 17667 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14557570 [rel_patent_id] =>[rel_patent_doc_number] =>)